Css LLC Intercept Pharmaceuticals, Inc. Put Options Transaction History

Css LLC

14 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 15, 2022	SELL	$11.23 - $19.59 $56,150 - $97,950	-5,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$13.37 - $17.79 $58,828 - $78,276	4,400 Added 733.33%	5,000 $81,000
Q4 2021 Feb 14, 2022	BUY	$14.28 - $19.53 $8,568 - $11,718	600 New	600 $10,000
Q2 2021 Aug 16, 2021	SELL	$15.46 - $24.5 $166,968 - $264,600	-10,800 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$19.33 - $37.75 $721,008 - $1.41 Million	-37,300 Reduced 77.55%	10,800 $249,000
Q4 2020 Feb 16, 2021	BUY	$24.48 - $42.47 $521,424 - $904,611	21,300 Added 79.48%	48,100 $1.19 Million
Q3 2020 Nov 16, 2020	BUY	$39.09 - $53.44 $195,450 - $267,200	5,000 Added 22.94%	26,800 $1.11 Million
Q2 2020 Aug 14, 2020	BUY	$46.7 - $92.04 $9,340 - $18,408	200 Added 0.93%	21,800 $1.05 Million
Q4 2019 Feb 14, 2020	BUY	$57.36 - $124.1 $820,248 - $1.77 Million	14,300 Added 195.89%	21,600 $2.68 Million
Q3 2019 Nov 14, 2019	BUY	$58.69 - $80.46 $422,568 - $579,312	7,200 Added 7200.0%	7,300 $485,000
Q2 2019 Aug 14, 2019	SELL	$77.77 - $120.68 $272,195 - $422,380	-3,500 Reduced 97.22%	100 $8,000
Q1 2019 May 15, 2019	BUY	$91.83 - $120.68 $330,588 - $434,448	3,600 New	3,600 $403,000
Q1 2018 May 15, 2018	SELL	$52.72 - $67.25 $711,720 - $907,875	-13,500 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$57.01 - $118.75 $769,635 - $1.6 Million	13,500	13,500 $783,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.